Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.
Centro de Biotecnología Acuícola, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.
Front Public Health. 2023 Jul 10;11:1191377. doi: 10.3389/fpubh.2023.1191377. eCollection 2023.
As the SARS-CoV-2 continues to evolve, new variants pose a significant threat by potentially overriding the immunity conferred by vaccination and natural infection. This scenario can lead to an upswing in reinfections, amplified baseline epidemic activity, and localized outbreaks. In various global regions, estimates of breakthrough cases associated with the currently circulating viral variants, such as Omicron, have been reported. Nonetheless, specific data on the reinfection rate in Chile still needs to be included.
Our study has focused on estimating COVID-19 reinfections per wave based on a sample of 578,670 RT-qPCR tests conducted at the University of Santiago of Chile (USACH) from April 2020 to July 2022, encompassing 345,997 individuals.
The analysis reveals that the highest rate of reinfections transpired during the fourth and fifth COVID-19 waves, primarily driven by the Omicron variant. These findings hold despite 80% of the Chilean population receiving complete vaccination under the primary scheme and 60% receiving at least one booster dose. On average, the interval between initial infection and reinfection was found to be 372 days. Interestingly, reinfection incidence was higher in women aged between 30 and 55. Additionally, the viral load during the second infection episode was lower, likely attributed to Chile's high vaccination rate.
This study demonstrates that the Omicron variant is behind Chile's highest number of reinfection cases, underscoring its potential for immune evasion. This vital epidemiological information contributes to developing and implementing effective public health policies.
随着 SARS-CoV-2 的持续进化,新的变种通过潜在地颠覆疫苗和自然感染所赋予的免疫力,构成了重大威胁。这种情况可能导致再次感染的增加、基础流行活动的放大和局部爆发。在全球各个地区,都有报道称与当前流行的病毒变种(如奥密克戎)相关的突破性病例的估计。然而,智利再感染率的具体数据仍有待纳入。
我们的研究集中于根据智利圣地亚哥大学(USACH)从 2020 年 4 月至 2022 年 7 月进行的 578670 次 RT-qPCR 测试的样本,估计每一波 COVID-19 再感染,涵盖了 345997 个人。
分析表明,第四次和第五次 COVID-19 波期间再感染率最高,主要由奥密克戎变种驱动。尽管智利 80%的人口按照初级方案完全接种疫苗,60%的人至少接种了一剂加强针,但仍出现了这些发现。平均而言,初次感染和再次感染之间的间隔为 372 天。有趣的是,30 至 55 岁的女性中再感染的发生率更高。此外,第二次感染时的病毒载量较低,可能归因于智利的高疫苗接种率。
这项研究表明,奥密克戎变种是智利再感染病例最多的原因,突出了其免疫逃避的潜力。这些重要的流行病学信息有助于制定和实施有效的公共卫生政策。